In the present study, we characterized the transcriptome signature of CD16+ monocytes at a single cell-level to characterize the biology and immune response of these cells in people with and without SARS-CoV-2 infection, as well as to compare those with mild and severe COVID-19. This evidence concerns the gene FCGR3A and COVID-19.